Is ML or ABBV a better dividend investment in 2026?

ML currently yields 2.33% with a 5% 5-year dividend growth rate. ABBV yields 3.67% with 8.9% growth. The better choice depends on your goal: ABBV offers higher current income.

What is the dividend yield difference between ML and ABBV?

ML has a forward dividend yield of 2.33% ($2.00/share annually). ABBV yields 3.67% ($6.20/share annually). The yield gap is 1.34 percentage points.

Home › Compare › ML vs ABBV

ML vs ABBV: Dividend Comparison 2026

ML yields 2.33% · ABBV yields 3.67%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ABBV wins by $16.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

● Live price

2.33%

Share price

$85.90

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$23.1K

Annual income

$270.61

Full ML calculator →

ABBV

AbbVie Inc.

● Live price

3.67%

Share price

$168.90

Annual div

$6.20

5Y div CAGR

8.9%

Payout ratio

58%

After 10 yrs · $10,000 · DRIP

Portfolio value

$39.9K

Annual income

$1,154.43

Full ABBV calculator →

Portfolio growth — ML vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ML	ABBV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ML + ABBV cover 4 of 12 months — good coverage

Jan

ABBV

Feb

—

Mar

—

Apr

ABBV

May

—

Jun

—

Jul

ABBV

Aug

—

Sep

—

Oct

ABBV

Nov

—

Dec

—

ML pays

ABBV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

Annual income on $10K today (after 15% tax)

$197.90/yr

After 10yr DRIP, annual income (after tax)

$230.02/yr

ABBV

Annual income on $10K today (after 15% tax)

$312.02/yr

After 10yr DRIP, annual income (after tax)

$981.27/yr

At 15% tax rate, ABBV beats the other by $751.25/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ML + ABBV for your $10,000?

ML: 50%ABBV: 50%

100% ABBV50/50100% ML

Portfolio after 10yr

$31.5K

Annual income

$712.53/yr

Blended yield

2.26%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$84.20

-2.0% upside vs current

Range: $60.00 — $109.00

Altman Z

2.4

Piotroski

7/9

ABBV

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$256.15

+51.7% upside vs current

Range: $223.00 — $299.00

Altman Z

2.0

Piotroski

8/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ML buys

ABBV buys

No recent congressional trades found for ML or ABBV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMLABBV

Forward yield	2.33%	3.67% ✓
Annual dividend / share	$2.00	$6.20 ✓
Payout ratio	50% ✓	58%
1-year div growth	0%	4.7% ✓
5-year div CAGR	0%	8.9% ✓
Portfolio after 10y	$23.1K	$39.9K ✓
Annual income after 10y	$270.61	$1,154.43 ✓
Total dividends collected	$2.5K	$7.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy
Analyst price target	$84.20	$256.15 ✓

Year-by-year: ML vs ABBV ($10,000, DRIP)

Year	ML Portfolio	ML Income/yr	ABBV Portfolio	ABBV Income/yr	Gap
1← crossover	$10,933	$232.83	$11,520	$399.75	$587.00 → ABBV
2	$11,936	$237.90	$13,261	$450.98	$1.3K → ABBV
3	$13,014	$242.73	$15,255	$508.41	$2.2K → ABBV
4	$14,173	$247.35	$17,536	$572.74	$3.4K → ABBV
5	$15,416	$251.74	$20,145	$644.78	$4.7K → ABBV
6	$16,752	$255.92	$23,126	$725.38	$6.4K → ABBV
7	$18,184	$259.89	$26,532	$815.52	$8.3K → ABBV
8	$19,721	$263.66	$30,420	$916.26	$10.7K → ABBV
9	$21,368	$267.23	$34,855	$1,028.80	$13.5K → ABBV
10	$23,135	$270.61	$39,914	$1,154.43	$16.8K → ABBV

ML vs ABBV: Complete Analysis 2026

ML — Stock

MoneyLion Inc. provides a digital financial platform. The company's platform offers access to banking, borrowing, and investing solutions for customers. Its principal products include roarmoney premium mobile banking, personalized investing, cryptocurrency, instacash, membership programs, financial tracking tools, online financial education content destination, affiliated marketing programs, unsecured personal loans, and credit-related decision servicing. The company was founded in 2013 and is headquartered in New York, New York.

Full ML Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →

📬

Get this ML vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ML vs SCHD ML vs JEPI ML vs O ML vs KO ML vs MAIN ML vs JNJ ML vs MRK ML vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.